©The Author(s) 2025.
World J Diabetes. Sep 15, 2025; 16(9): 110590
Published online Sep 15, 2025. doi: 10.4239/wjd.v16.i9.110590
Published online Sep 15, 2025. doi: 10.4239/wjd.v16.i9.110590
Table 2 Multivariate analysis of the association between bilirubin indices and the risk of developing diabetic retinopathy
| Variables | Model 1 | Model 2 | Model 3 | |||
| OR (95%CI) | P value | OR (95%CI) | P value | OR (95%CI) | P value | |
| IBIL | 0.423 (0.361-0.496) | < 0.001b | 0.480 (0.407-0.565) | < 0.001b | 0.500 (0.363-0.686) | < 0.001b |
| DBIL | 0.480 (0.365-0.630) | < 0.001b | 0.637 (0.486-0.834) | 0.001a | 1.029 (0.860-1.231) | 0.754 |
| TBIL | 0.568 (0.507-0.636) | < 0.001b | 0.634 (0.565-0.712) | < 0.001b | 0.837 (0.693-1.011) | 0.837 |
- Citation: Lin XY, Zheng YX, Liu MM, Liang Q, Li M, Sui J, Qiang W, Guo H, Shi BY, He MQ. Indirect bilirubin is inversely associated with diabetic retinopathy risk and is a potential predictive biomarker. World J Diabetes 2025; 16(9): 110590
- URL: https://www.wjgnet.com/1948-9358/full/v16/i9/110590.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i9.110590